Skip to content
Business websites
Business websites
Johnson & Johnson
J&J MedTech
Johnson & Johnson
J&J MedTech
South Africa
Language
English
Choose your local market.
Global
Global
English
North America
Canada
English
Français
United States
English
Asia Pacific
Asia Pacific (Regional)
English
Australia
English
China
中文
Hong Kong
English
中文
India
English
Japan
日本
Korea
한국어
New Zealand
English
Europe, Middle East & Africa (EMEA)
EMEA (Regional)
English
Austria
Deutsch
Belgium
English
Français
Nederlands
Bulgaria
БЪЛГАРСКИ
Croatia
Hrvatski
Czech Republic
čeština
Denmark
Dansk
Estonia
English
Finland
Suomi
France
Français
Germany
Deutsch
Greece
ΕΛΛΗΝΙΚΑ
Hungary
Magyar
Ireland
English
Israel
עברית
Italy
Italiano
Latvia
English
Lithuania
English
Netherlands
Nederlands
Norway
Norsk
Poland
Polski
Portugal
Português
Romania
Română
Russia
Pусский
Serbia
Srpski
Slovakia
Slovenčina
Slovenia
Slovenščina
South Africa
English
Spain
Español
Switzerland
Français
Deutsch
Sweden
Svensk
Turkey
Türkçe
United Kingdom
English
Latin America
Latin America (Regional)
Español
Argentina
Español
Bolivia
Español
Brazil
Português
Central America & the Carribbean
Español
English
Chile
Español
Colombia
Español
Ecuador
Español
Mexico
Español
Paraguay
Español
Peru
Español
Uruguay
Español
About us
Our Credo
Our heritage
Contact us
Our innovation
Focus areas
Oncology
Immunology
Neuroscience
Pulmonary Hypertension (PH)
Newsroom
About us
Our Credo
Our heritage
Contact us
Our innovation
Focus areas
Oncology
Immunology
Neuroscience
Pulmonary Hypertension (PH)
Newsroom
Menu
Search Query
Submit Search
Clear
Dictate search request
Search Results
No Results
Recently Viewed
innovativemedicine.jnj.com/south-africa/newsroom
Listening...
Sorry, I don't understand. Please try again
Show Search
South Africa
/
Newsroom
Newsroom
The latest news, information and stories from Johnson & Johnson Innovative Medicine South Africa.
Newsroom
Important Medicine Safety Information
Read more
Press releases
Search Query
Submit Search
Clear
Dictate search request
Listening...
Sorry, I don't understand. Please try again
18 Results
18 Results
Open
Filters
Sort By
Newest
Newest
Oldest
Relevance
Johnson & Johnson Marks New Era as Global Healthcare Company with Updated Visual Identity
Janssen adopts J&J name as part of global rebranding initiative
December 5, 2024
Read more
Newsroom
Important Medicine Safety Information
June 20, 2024
Read more
Newsroom
Recommended Calculations Of Contraception Duration After Completion Of Therapy To Minimise The Risk Of Embryotoxicity And Teratogenicity Associated With The Use Of Genotoxic Anticancer Medicines (Including Potential Metabolites)
April 26, 2024
Read more
Newsroom
February 28 is Rare Disease Day
February 28 marks the 7th annual Rare Disease Day, an important international occasion to raise awareness of rare diseases and their impact on people living with these conditions.
February 28, 2024
Read more
Newsroom
Johnson & Johnson Statement on COVID-19 Vaccine Contract Disclosures
September 5, 2023
Read more
Newsroom
Janssen Announces Collaboration with Acino to Strengthen Patient Access in South Africa
Acino to market and sell several Janssen products mainly within the pain, neuroscience and anti-fungal therapeutic areas
May 15, 2023
Read more
1 of 3
Next
CP-497735 | January 2025